MindWalk Holdings Corp. (HYFT) is the 75th largest of 96 Contract Research companies by market capitalisation, at 61.69 Mn, behind NutriBand Inc. at 67.22 Mn. The table below compares all 96 on 8 financial metrics.
| # | Ticker | Company | match | industry_code | industry_group | industry_group_code | Market Capitalization | P/E | P/S | Enterprise Value |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | IQV | Iqvia Holdings Inc. | primary | H-11 | Pharma Services | HG-03 | 44.19 Bn | 33.48 | 2.60 | 42.11 Bn |
| 2 | MEDP | Medpace Holdings, Inc. | primary | H-11 | Pharma Services | HG-03 | 16.72 Bn | 34.02 | 6.01 | 16.22 Bn |
| 3 | CRL | Charles River Laboratories International, Inc. | primary | H-11 | Pharma Services | HG-03 | 13.89 Bn | -58.45 | 3.47 | 13.70 Bn |
| 4 | ICLR | Icon Plc | primary | H-11 | Pharma Services | HG-03 | 12.81 Bn | 16.47 | 1.55 | 12.81 Bn |
| 5 | FTRE | Fortrea Holdings Inc. | primary | H-11 | Pharma Services | HG-03 | 1.73 Bn | -20.27 | 0.65 | 1.56 Bn |
| 6 | EVO | Evotec SE | primary | H-11 | Pharma Services | HG-03 | 0.66 Bn | — | — | 0.23 Bn |
| 7 | DNA | Ginkgo Bioworks Holdings, Inc. | primary | H-11 | Pharma Services | HG-03 | 0.43 Bn | -1.47 | 3.82 | 0.34 Bn |
| 8 | CSBR | Champions Oncology, Inc. | primary | H-11 | Pharma Services | HG-03 | 0.07 Bn | -61.57 | 1.22 | 0.07 Bn |
| 9 | HYFT | MindWalk Holdings Corp. | primary | H-11 | Pharma Services | HG-03 | 0.06 Bn | -10.10 | 5.47 | 0.05 Bn |
| 10 | VIVS | VivoSim Labs, INC. | primary | H-11 | Pharma Services | HG-03 | 0.00 Bn | -0.13 | 13.19 | 0.00 Bn |
| 11 | NOTVQ | Inotiv, Inc. | primary | H-11 | Pharma Services | HG-03 | 0.00 Bn | 0.00 | 0.00 | -0.01 Bn |
| 12 | TMO | Thermo Fisher Scientific Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 226.11 Bn | 32.12 | 4.88 | 222.04 Bn |
| 13 | PFE | Pfizer Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 162.11 Bn | 37.11 | 2.55 | 150.41 Bn |
| 14 | TEVA | Teva Pharmaceutical Industries Ltd | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 42.66 Bn | 61.30 | 2.46 | 39.01 Bn |
| 15 | ZTS | Zoetis Inc. | secondary | H-05 | Pharmaceuticals and Biotechnology | HG-01 | 31.39 Bn | 9.59 | 3.30 | 29.71 Bn |
| 16 | LH | Labcorp Holdings Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 26.87 Bn | 26.77 | 1.87 | 26.72 Bn |
| 17 | WST | West Pharmaceutical Services Inc | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 24.24 Bn | 44.13 | 7.29 | 23.81 Bn |
| 18 | IFF | International Flavors & Fragrances Inc | secondary | M-02 | Chemicals | MG-01 | 21.93 Bn | 75.11 | 2.20 | 21.36 Bn |
| 19 | STE | STERIS plc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 21.83 Bn | 27.01 | 3.62 | 21.34 Bn |
| 20 | GH | Guardant Health, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 20.84 Bn | -45.97 | 17.62 | 19.79 Bn |
| 21 | VTRS | Viatris Inc | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 19.61 Bn | -47.74 | 1.33 | 18.72 Bn |
| 22 | LDOS | Leidos Holdings, Inc. | secondary | I-02 | Aerospace and Defense | IG-01 | 16.74 Bn | 12.00 | 0.95 | 16.00 Bn |
| 23 | DVA | Davita Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 11.79 Bn | 10.12 | 0.84 | 11.10 Bn |
| 24 | TEM | Tempus AI, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 11.59 Bn | -46.65 | 8.09 | 10.77 Bn |
| 25 | PODD | Insulet Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 10.09 Bn | 26.87 | 3.30 | 9.55 Bn |
| 26 | RDY | Dr Reddys Laboratories Ltd | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 9.91 Bn | 785.46 | 2.70 | 9.74 Bn |
| 27 | IONS | Ionis Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 9.63 Bn | -45.39 | 11.02 | 7.58 Bn |
| 28 | TWST | Twist Bioscience Corp | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 7.82 Bn | -57.20 | 18.11 | 7.65 Bn |
| 29 | ALKS | Alkermes plc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 7.76 Bn | 117.27 | 4.65 | 7.10 Bn |
| 30 | CAI | Caris Life Sciences, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 6.99 Bn | 66.50 | 7.07 | 6.20 Bn |
| 31 | LNTH | Lantheus Holdings, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 6.57 Bn | 23.88 | 4.22 | 5.98 Bn |
| 32 | LQDA | Liquidia Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.05 Bn | 43.63 | 13.41 | 5.76 Bn |
| 33 | LGND | Ligand Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.78 Bn | 29.30 | 19.89 | 4.42 Bn |
| 34 | GRFS | Grifols SA | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.30 Bn | 20.88 | 0.32 | 4.14 Bn |
| 35 | TLX | Telix Pharmaceuticals Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.02 Bn | — | — | 3.73 Bn |
| 36 | ADPT | Adaptive Biotechnologies Corp | secondary | H-17 | Healthcare Providers | HG-04 | 3.86 Bn | -95.86 | 12.53 | 3.51 Bn |
| 37 | OGN | Organon & Co. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.62 Bn | 17.31 | 0.59 | 2.49 Bn |
| 38 | ABCL | AbCellera Biologics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.49 Bn | -21.19 | 52.73 | 3.49 Bn |
| 39 | BHC | Bausch Health Companies Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 2.49 Bn | -2.28 | 0.23 | 0.66 Bn |
| 40 | NEO | Neogenomics Inc | secondary | H-17 | Healthcare Providers | HG-04 | 2.23 Bn | -43.04 | 2.91 | 2.09 Bn |
| 41 | ADMA | Adma Biologics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.15 Bn | 12.93 | 4.20 | 2.02 Bn |
| 42 | SCNI | Scinai Immunotherapeutics Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.77 Bn | -210.74 | 1,025.06 | 1.76 Bn |
| 43 | NVAX | Novavax Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.67 Bn | -6.73 | 4.03 | 0.95 Bn |
| 44 | IART | Integra Lifesciences Holdings Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.27 Bn | -174.90 | 0.77 | 0.99 Bn |
| 45 | MGTX | MeiraGTx Holdings plc | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.25 Bn | 7.56 | 3.11 | 1.10 Bn |
| 46 | MRVI | Maravai Lifesciences Holdings, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 1.08 Bn | -7.94 | 5.17 | 1.01 Bn |
| 47 | AMPH | Amphastar Pharmaceuticals, Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 1.02 Bn | 12.23 | 1.40 | 0.73 Bn |
| 48 | LXRX | Lexicon Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.97 Bn | -15.41 | 23.38 | 0.78 Bn |
| 49 | QDEL | QuidelOrtho Corp | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.95 Bn | — | — | 0.83 Bn |
| 50 | AVR | Anteris Technologies Global Corp. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.85 Bn | -10.28 | 381.20 | 0.85 Bn |
| 51 | AQST | Aquestive Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.67 Bn | -8.60 | 12.44 | 0.67 Bn |
| 52 | STLN | Starling Oncology, Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 0.61 Bn | -20.06 | 1.04 | 0.57 Bn |
| 53 | OABI | OmniAb, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.59 Bn | -13.32 | 15.34 | 0.54 Bn |
| 54 | RGNX | REGENXBIO Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.47 Bn | -2.67 | 2.50 | 0.37 Bn |
| 55 | CLPT | ClearPoint Neuro, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.42 Bn | -14.36 | 9.90 | 0.39 Bn |
| 56 | EYPT | EyePoint, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.40 Bn | -1.28 | 142.43 | 0.22 Bn |
| 57 | WDH | Waterdrop Inc. | secondary | F-16 | Insurance | FG-04 | 0.39 Bn | 4.88 | 0.61 | 0.26 Bn |
| 58 | EMBC | Embecta Corp. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.34 Bn | 3.84 | 0.33 | 0.12 Bn |
| 59 | STRO | Sutro Biopharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.33 Bn | -2.94 | 3.71 | 0.17 Bn |
| 60 | EBS | Emergent BioSolutions Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.32 Bn | -1.82 | 0.42 | 0.18 Bn |
| 61 | IMRX | Immuneering Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.31 Bn | -5.33 | — | 0.31 Bn |
| 62 | MGNX | Macrogenics Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.27 Bn | -16.73 | 1.61 | 0.16 Bn |
| 63 | BDSX | Biodesix Inc | secondary | H-17 | Healthcare Providers | HG-04 | 0.27 Bn | -9.35 | 2.61 | 0.24 Bn |
| 64 | OSUR | Orasure Technologies Inc | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.26 Bn | — | 2,566.09 | 0.06 Bn |
| 65 | YDES | YD Bio Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.24 Bn | -19.42 | 287.04 | 0.24 Bn |
| 66 | UTMD | Utah Medical Products Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.23 Bn | 22.98 | 6.28 | 0.14 Bn |
| 67 | AGPU | Axe Compute Inc. | secondary | T-44 | Cloud Computing | TG-07 | 0.20 Bn | -7.88 | — | 0.17 Bn |
| 68 | XGN | Exagen Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 0.18 Bn | -9.59 | 2.55 | 0.16 Bn |
| 69 | KRMD | KORU Medical Systems, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.15 Bn | -63.03 | 3.28 | 0.14 Bn |
| 70 | IMDX | Insight Molecular Diagnostics Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.15 Bn | -2.71 | 88.02 | 0.13 Bn |
| 71 | MXCT | Maxcyte, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.14 Bn | -3.87 | 4.44 | 0.14 Bn |
| 72 | APYX | Apyx Medical Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.14 Bn | -15.64 | 2.31 | 0.11 Bn |
| 73 | CDXS | Codexis, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.13 Bn | -4.31 | 1.71 | 0.08 Bn |
| 74 | BNR | Burning Rock Biotech Ltd | secondary | H-17 | Healthcare Providers | HG-04 | 0.10 Bn | -11.34 | 1.25 | 0.03 Bn |
| 75 | PTHS | Pelthos Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -0.78 | 1.62 | 0.06 Bn |
| 76 | XBIT | XBiotech Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -1.62 | — | 0.07 Bn |
| 77 | NTRB | NutriBand Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -2.25 | 37.29 | 0.06 Bn |
| 78 | LASE | Laser Photonics Corp | secondary | I-04 | Machinery | IG-02 | 0.05 Bn | -1.50 | 8.86 | 0.05 Bn |
| 79 | CELU | Celularity Inc | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.49 | 1.68 | 0.04 Bn |
| 80 | SCLX | Scilex Holding Co | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.08 | 1.17 | -0.08 Bn |
| 81 | BHST | Bioharvest Sciences Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -3.11 | 0.94 | 0.02 Bn |
| 82 | NSYS | Nortech Systems Inc | secondary | I-04 | Machinery | IG-02 | 0.03 Bn | 12.07 | 0.37 | 0.03 Bn |
| 83 | ABVC | Abvc Biopharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -3.49 | — | 0.02 Bn |
| 84 | LGVN | Longeveron Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.89 | 17.71 | 0.01 Bn |
| 85 | COSM | Cosmos Health Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.77 | 0.21 | 0.01 Bn |
| 86 | PLUR | Pluri Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | 0.00 | 9.75 | 0.00 Bn |
| 87 | NAII | Natural Alternatives International Inc | secondary | H-12 | Pharma Services | HG-03 | 0.01 Bn | -0.89 | 0.09 | 0.00 Bn |
| 88 | PBSV | Pharma-Bio Serv, Inc. | secondary | I-26 | Business Services | IG-06 | 0.01 Bn | 220.48 | 1.26 | 0.00 Bn |
| 89 | BFRG | BullFrog AI Holdings, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -1.62 | 28.60 | 0.00 Bn |
| 90 | GELS | Gelteq Ltd | secondary | H-12 | Pharma Services | HG-03 | 0.01 Bn | — | — | 0.01 Bn |
| 91 | AIDX | 20/20 Biolabs, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 0.01 Bn | -1.03 | 3.08 | 0.00 Bn |
| 92 | DQWS | DSwiss Inc | secondary | S-11 | Household and Personal Products | SG-05 | 0.01 Bn | -27.32 | 4.18 | 0.01 Bn |
| 93 | CLGN | CollPlant Biotechnologies Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.68 | 11.53 | 0.00 Bn |
| 94 | NXGL | Nexgel, Inc. | secondary | H-12 | Pharma Services | HG-03 | 0.00 Bn | -0.51 | 0.24 | 0.00 Bn |
| 95 | SKVI | Skinvisible, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -2.25 | 116.18 | 0.00 Bn |
| 96 | CPMV | Mosaic ImmunoEngineering Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -1.27 | — | 0.00 Bn |